InvestorsHub Logo
Followers 1
Posts 47
Boards Moderated 0
Alias Born 09/27/2013

Re: pijoe post# 16957

Tuesday, 07/29/2014 5:17:23 PM

Tuesday, July 29, 2014 5:17:23 PM

Post# of 113655
Per the prospectus filed yesterday ~ "In particular, our multi-purpose anti-tumor compound, Adva-27a, expects to be entering Phase I clinical trials for multidrug resistant breast cancer indication during 2014, provided that we are successful in obtaining the funding necessary to conduct these trials. We expected that we would begin these clinical trials during 2012, but were unable to secure sufficient funding to undertake this activity. While we believe that the funds received from Dutchess will be sufficient to allow us to complete our initial clinical trials there can be no assurances that we will have sufficient funds to complete the same, or that these trials will be successful."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News